The medical community is advocating for the renaming of Polycystic Ovarian Syndrome (PCOS) to Polyendocrine Metabolic Ovarian Syndrome (PMOS) to better represent the condition's complexity. The term 'cysts' has often misled women into believing they do not have PCOS if their ultrasounds do not show cysts, despite experiencing symptoms like irregular periods, weight gain, and insulin resistance. Dr. Preethi Prabhakar Shetty, an obstetrician in Bangalore, emphasizes that the follicles seen on ultrasounds are not true cysts but immature egg follicles due to hormonal imbalance. This misconception has led to delayed diagnoses and inadequate treatment. Experts stress that diagnosis should involve a holistic approach, including clinical symptoms and metabolic assessments, rather than relying solely on ultrasound results. The proposed name change to PMOS is expected to empower women, reduce stigma, and promote comprehensive care addressing metabolic and endocrine issues beyond fertility concerns. For many women who have felt overlooked by the healthcare system, this change signifies a crucial step towards better understanding and treatment of their condition.